Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Minimally invasive surgeries are characterized by smaller incisions made in the patient’s body for surgical treatment of a disease or condition, causing less trauma to the patient and faster recovery time. Types of minimally invasive surgery include, robotic surgery and non-robotic minimally invasive surgery (endoscopic).

Statistics:

The global minimally invasive surgery market is estimated to account for US$ 113,866.8 Mn in terms of value by the end of 2027.

Global Minimally Invasive Surgery Market: Drivers

Increasing prevalence of chronic disorders is expected to propel growth of the global minimally invasive surgery market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, increase geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Statistics:

North America held dominant position in the global minimally invasive surgery market in 2019, accounting for 45.0% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1: Global Minimally Invasive Surgery Market Share (%) Value, By Region, 2019

Minimally Invasive Surgery  | Coherent Market Insights

Global Minimally Invasive Surgery Market: Restraints

Lack of reimbursement is expected to hinder growth of the market. Currently, a small number of minimally invasive surgeries such as cryosurgery of prostate cancer are reimbursed by various governments. Various minimally invasive surgeries such as cardiovascular, gynecological, cosmetic and urological surgeries are not reimbursed by private and government insurance players in various nations. Lack of reimbursement for these surgeries may hamper growth of the market.

Moreover, high cost of minimally invasive surgeries is also expected to limit growth of the market. For instance, the purchase and installation cost of the da Vinci system ranges between US$ 1.5 million to US$ 2.5 million and the procedure cost ranges between US$ 3,000 to US$ 8,000. Similarly, the price of an endoscope ranges between US$ 30,000 to US$ 40,000 and the procedure cost for the same ranges between US$ 2,000 to US$ 3,000.

request-sample

Minimally Invasive Surgery Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 50,599.8 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 10.7% 2027 Value Projection: US$ 113,866.8 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Device Type:
    • Surgical Devices: Ablation Devices, Electrosurgical Devices, Medical Robotic Systems.
    • Monitoring & Visualization Devices, Endoscopy Devices.
  • By Surgery Type: Orthopedic Surgery, Cosmetic Surgery, Breast Surgery, Vascular Surgery, Thoracic Surgery, Gynecological Surgery, Bariatric Surgery, Cardiac Surgery, Gastrointestinal Surgery, Urological Surgery
Companies covered:

Abbott Laboratories, Inc., ArthroCare Corporation, Integer Holdings Corporation, Biomet, Inc., DePuy Synthes, Inc., GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic, plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., and Biom’up SA.

Growth Drivers:
  • Increasing prevalence of chronic disorders
  • Approval and launch of new products
Restraints & Challenges:
  • Product recall

Global Minimally Invasive Surgery Market: Opportunities

Increasing public hospital expenditure is expected to offer lucrative growth opportunities for players in the global minimally invasive surgery market. For instance, in August 2019, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, public hospital expenditure increased by 3.3% between 2016-2017 and 2017-2018.

Moreover, R&D in polymeric microarray patches is also expected to aid in growth of the market. For instance, in May 2020, researchers from Medical Biology Center, U.K., reported comparing the performance of hydrogel-forming microarray patches cast using novel industrially manufactured micromoulds with a high needle density to that of microarray patches obtained using conventional moulds with a lower density.

Statistics:

The global minimally invasive surgery market was valued at US$ 50,599.8 Mn in 2019 and is forecast to reach a value of US$ 113,866.8 Mn by 2027 at a CAGR of 10.7% between 2020 and 2027.

Figure 2: Global Minimally Invasive Surgery Market Value (US$ Mn), 2016 – 2027

Minimally Invasive Surgery  | Coherent Market Insights

Market Trends/Key Takeaways

The market is witnessing increasing M&A activities. For instance, in September 2019, Integra LifeSciences Holdings Corporation acquired Rebound Therapeutics, a developer of single-use medical devices that enable minimally invasive access in neurosurgery.

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2018, Medtronic plc received CE Mark approval for the Valiant Navion thoracic stent graft system for the minimally invasive repair of blunt traumatic aortic injuries, penetrating atherosclerotic ulcers, and others.

Global Minimally Invasive Surgery Market: Competitive Landscape

Major players operating in the global minimally invasive surgery market include, Abbott Laboratories, Inc., ArthroCare Corporation, Integer Holdings Corporation, Biomet, Inc., DePuy Synthes, Inc., GE Healthcare,  Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic, plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., and Biom’up SA.

Global Minimally Invasive Surgery Market: Key Developments

Major players in the market are focused on adopting partnership strategies to expand their product portfolio. For instance, in June 2020, Titan Medical Inc. entered into a development and license agreement with Medtronic plc for R&D in robotic assisted surgical technologies.

Major players in the market are also focused on approval and launch of new products to expand their product portfolio. For instance, in October 2019, InMode Ltd. received Health Canada Certification for AccuTite, a minimally invasive technology that delivers RF heating.

Minimally Invasive Surgery are performed using smaller incisions made in the patient’s body for surgical treatment of a disease or condition, causing less trauma to the patient and faster recovery time. Minimally invasive surgery include, robotic surgery and non-robotic minimally invasive surgery. Increasing prevalence of chronic disorders, and increasing demand for minimally invasive procedures is expected to drive the market growth during the forecast period. Furthermore, new product approval and increasing incidences of chronic diseases is also expected to assist the market growth.

Key features of the study:

  • This report provides in-depth analysis of the Global Minimally Invasive Surgery market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Minimally Invasive Surgery market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, Inc., ArthroCare Corporation, Integer Holdings Corporation, Biomet, Inc., DePuy Synthes, Inc., GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., and Biom’up SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Minimally Invasive Surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Minimally Invasive Surgery market

Detailed Segmentation:

  • Global Minimally Invasive Surgery Market, By Device Type:
    • Surgical Devices
      • Ablation Devices
      • Electrosurgical Devices
      • Medical Robotic Systems
    • Monitoring & Visualization Devices
    • Endoscopy Devices
  • Global Minimally Invasive Surgery Market, By Surgery:
    • Orthopedic Surgery
    • Cosmetic Surgery
    • Breast Surgery
    • Vascular Surgery
    • Thoracic Surgery
    • Gynecological Surgery
    • Bariatric Surgery
    • Cardiac Surgery
    • Gastrointestinal Surgery
    • Urological Surgery
  • Global Minimally Invasive Surgery Market, By Region:
    • North America
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Device Type:
        • Surgical Devices
          • Ablation Devices
          • Electrosurgical Devices
          • Medical Robotic Systems
        • Monitoring & Visualization Devices
        • Endoscopy Devices
      • By Surgery
        • Orthopedic Surgery
        • Cosmetic Surgery
        • Breast Surgery
        • Vascular Surgery
        • Thoracic Surgery
        • Gynecological Surgery
        • Bariatric Surgery
        • Cardiac Surgery
        • Gastrointestinal Surgery
        • Urological Surgery
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Abbott Laboratories, Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • ArthroCare Corporation
    • Integer Holdings Corporation
    • Biomet, Inc.
    • DePuy Synthes, Inc.
    • GE Healthcare
    • Given Imaging Ltd.
    • Intuitive Surgical, Inc.
    • Medtronic, plc.
    • NuVasive, Inc.
    • Philips Healthcare
    • InMode Ltd.
    • Titan Medical Inc.
    • Fractyl Inc.
    • Biom’up SA
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Device Type
      • Market Snippet, By Surgery
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • Impact of COVID19 on the market
  4. Global Minimally Invasive Surgery Market, By Device Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Surgical Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Ablation Devices
        • Electrosurgical Devices
        • Medical Robotic Systems
    • Monitoring & Visualization Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Endoscopy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Impact of COVID19 on the market
  5. Global Minimally Invasive Surgery Market, By Surgery, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Orthopedic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cosmetic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Breast Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Vascular Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Thoracic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gynecological Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bariatric Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cardiac Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gastrointestinal Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Urological Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Minimally Invasive Surgery Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Device Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Surgery, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ArthroCare Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Integer Holdings Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biomet, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DePuy Synthes, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Conmed Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Given Imaging Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Intuitive Surgical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic, plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NuVasive, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Philips Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • InMode Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Titan Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fractyl Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biom’up SA.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 28 market data tables and 18 figures on “Minimally Invasive Surgery Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Minimally Invasive Surgery market size was valued at US$ 50,599.8 million in 2019 and is estimated to exhibit a CAGR of 10.7% between 2020 and 2027.
Surgical Devices segment held the major market share in 2019 owing to an increasing prevalence of chronic disorders is expected to propel growth of the market.
Major factor driving the growth of Global Minimally Invasive Surgery market during the forecast period increasing prevalence of chronic disorders, increasing research & development , and adoption of expansion strategies from major companies.
Major factors hampering the growth of the Global Minimally Invasive Surgery market during the forecast period constitutes of Lack of reimbursement.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Abbott Laboratories, Inc., ArthroCare Corporation, Integer Holdings Corporation, Biomet, Inc., DePuy Synthes, Inc., GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., and Biom’up SA.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner